23andMe Inks $3.5B Deal With Richard Branson-Backed SPAC
By Benjamin Horney · February 4, 2021, 10:09 AM EST
Genetic testing company 23andMe, guided by Morgan Lewis, will trade publicly after merging with a Davis Polk-advised special purpose acquisition company backed by Richard Branson's Virgin Group, in a deal announced...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login